Zemea Propanediol Meets U.S. Environmental Protection Agency Design for the Environmen...(om onclick linkClick( this.href ); ta...)
Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
Zemea Propanediol Meets U.S. Environmental Protection Agency Design for the Environment Criteria
Date:12/30/2008
om" onclick="linkClick( this.href );" target="_blank">www.duponttateandlyle.com.
DuPont is a science-based products and services company. Founded in 1802, DuPont puts science to work by creating sustainable solutions essential to a better, safer, healthier life for people everywhere. Operating in more than 70 countries, DuPont offers a wide range of innovative products and services for markets including agriculture and food; building and construction; communications; and transportation.
The DuPont Oval Logo, DuPont™, The miracles of science™, and Bio-PDO™ are registered trademarks or trademarks of DuPont or its affiliates.
Zemea® is a registered trademark of DuPont Tate & Lyle Bio Products LLC.
CleanGredients® is a registered trademark of GreenBlue.
GreenBlue® is a registered trademark of GreenBlue.
###
Read the full story at http://www.prweb.com/releases/DuPont/Zemea_propanediol/prweb1807494.htm
'/>"/>
| Source: PRWeb Copyright©2008 Vocus, Inc. All rights reserved |
Related biology technology :
1. Zemea Propanediol Approved as a Natural Ingredient by ECOCERT
2. Anesiva Phase 3 Trial of Adlea Meets Primary Endpoint to Significantly Reduce Pain After Total Knee Replacement Surgery
3. Human Genome Sciences Announces Albuferon(R) Meets Primary Endpoint in Phase 3 Trial in Chronic Hepatitis C
4. Serica Technologies Receives ISO Certification, Meets International Standards for Medical Device Manufacturing
5. EntreMeds MKC-1 Meets Primary Efficacy Endpoint in Non-Small Cell Lung Cancer Clinical Trial
6. VNUS Medical Technologies, Inc. Announces the Hiring of Guido Smeets, MD, as Vice President of Clinical Research and Chief Medical Officer
7. Asenapine Meets Primary Endpoint in Long-Term Schizophrenia Relapse Prevention Trial
8. Cequent Pharmaceuticals Meets Novartis Option Fund Milestone; Continues to Next Phase to Validate Inflammatory Bowel Disease Targets in Vivo
9. Teliks Aurora Kinase-VEGFR Dual Inhibitor Program Meets a Preclinical Development Milestone
10. The Science of Music Meets the Art of Medicine - ARIMM 3rd Annual Conference at IPFW, September 12-13, 2008
11. Atherotech VAP Cholesterol Test Meets Updated ADA, ACC Measurement and Treatment Guidelines for High Risk Patients
Post Your Comments:
Related Image:
 Zemea Propanediol Meets U.S. Environmental Protection Agency Design for the Environment Criteria |
Breaking Biology Technology:New silicon-germanium nanowires could lead to smaller, more powerful electronic devices 2New silicon-germanium nanowires could lead to smaller, more powerful electronic devices 3Butler Hospital Neurologist Lead Author of Ground Breaking Bio-Engineered Treatment Study for Alzheimer's Disease 2MEDINA Scientists Select Genedata Screener for Lead Discovery from Natural Products 2MEDINA Scientists Select Genedata Screener for Lead Discovery from Natural Products 3MEDINA Scientists Select Genedata Screener for Lead Discovery from Natural Products 4Waters Ships First Units of SYNAPT G2 Mass Spectrometer 2
[0] New silicon-germanium nanowires could lead to smaller, more powerful electronic devices[0] Butler Hospital Neurologist Lead Author of Ground Breaking Bio-Engineered Treatment Study for Alzheimer's Disease[0] MEDINA Scientists Select Genedata Screener for Lead Discovery from Natural Products[0] Waters Ships First Units of SYNAPT G2 Mass Spectrometer
Other Biology Technology:Albemarle Manufactures Zymes' PTS, the Lead Compound in a Breakthrough Solubilization Technology 2Albemarle Manufactures Zymes' PTS, the Lead Compound in a Breakthrough Solubilization Technology 3Encorium Group Signs $3.1 Million of New Business Contracts Including an Extension of a Current U.S. Oncology Clinical Trial with a Major Pharmaceutical Company 2Encorium Group Signs $3.1 Million of New Business Contracts Including an Extension of a Current U.S. Oncology Clinical Trial with a Major Pharmaceutical Company 3Neogen Named Supplier of Chr. Hansen Probiotics for Swine and Poultry 2
Albemarle Manufactures Zymes' PTS, the Lead Compound in a Breakthrough Solubilization TechnologyEncorium Group Signs $3.1 Million of New Business Contracts Including an Extension of a Current U.S. Oncology Clinical Trial with a Major Pharmaceutical CompanyNeogen Named Supplier of Chr. Hansen Probiotics for Swine and Poultry
Breaking Biology News(10 mins):Study reveals H1N1 unexpected weakness 2From fruit fly wings to heart failure -- why Not(ch)? 2Hebrew University, American researchers show 'trigger' to stem cell differentiation 2Experts Urge One Test to Diagnose Diabetes 48085 1Experts Urge One Test to Diagnose Diabetes 48085 2Experts Urge One Test to Diagnose Diabetes 48085 3Express Scripts to Present at William Blair Growth Stock Conference 12491 1Express Scripts to Present at William Blair Growth Stock Conference 12491 2Pharmacyclics to Present at the 8th Annual Needham and Company Life Sciences Conference 12490 1Pharmacyclics to Present at the 8th Annual Needham and Company Life Sciences Conference 12490 2
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |